Summit Global Investments bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) in the 1st quarter, HoldingsChannel reports. The fund bought 6,729 shares of the company’s stock, valued at approximately $583,000.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. EFG International AG bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $38,000. Assetmark Inc. raised its stake in iShares U.S. Pharmaceuticals ETF by 203.9% during the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after acquiring an additional 312 shares during the period. O Shaughnessy Asset Management LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after acquiring an additional 120 shares during the period. Blueline Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth about $41,000. Finally, Accent Capital Management LLC bought a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $42,000.
iShares U.S. Pharmaceuticals ETF Stock Down 0.3%
Shares of NYSEARCA IHE opened at $100.64 on Thursday. The firm’s 50-day moving average price is $95.11 and its two-hundred day moving average price is $90.18. iShares U.S. Pharmaceuticals ETF has a 52-week low of $64.94 and a 52-week high of $103.70. The stock has a market capitalization of $1.44 billion, a P/E ratio of 17.75 and a beta of 0.49.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Featured Articles
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report).
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
